<DOC>
	<DOCNO>NCT01433107</DOCNO>
	<brief_summary>This study compare efficacy safety single dose terbinafine film form solution 1 % single dose placebo film form solution treatment tinea pedis .</brief_summary>
	<brief_title>Efficacy Safety Terbinafine Film Forming Solution Patients With Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>Patients â‰¥18 year age interdigital tinea pedis infection , clinical diagnosis meeting require baseline total sign &amp; symptom score positive microscopy Allergy allylamine class antimycotic excipients formulation . Chronic , hyperkeratotic plantar ( moccasin ) tinea pedis Other fungal disease intertrigo Other abnormal finding affect foot Systemic antifungal antimicrobial treatment within last 3 month Topical treatment skin lesion foot within last 3 month Diabetes mellitus peripheral artery occlusive disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Tinea pedis</keyword>
	<keyword>Terbinafine film form solution</keyword>
</DOC>